Shark cartilage monograph
This article was originally published in The Tan Sheet
Executive Summary
Institute of Medicine is requesting written comments on 1draft prototype monograph for shark cartilage by Oct. 6. Committee on the Framework for Evaluating the Safety of Dietary Supplements and its consultants will meet Oct. 7-8 to consider comments. Monograph, which was released Sept. 18, includes a description of dietary supplement preparations, amount ingested in ordinary use, human safety data, animal studies, sources of potential contamination and conditions of use suggested or recommended in labeling. IoM released a draft monograph on chaparral in August (2"The Tan Sheet" Sept. 9, 2002, p. 8). Committee also is scheduled to hold a public meeting Sept. 26 in Washington, D.C...
You may also be interested in...
Chaparral AER Data Resembles Kava Reports, CRN’s Cardellina Says
Adverse event reports on chaparral have certain parallels with those that have been filed for kava, according to Council for Responsible Nutrition VP-Botanical Science & Regulatory Affairs John Cardellina, PhD
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.